We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+16.99%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$75.2B
AUM Growth
+$9.1B
Cap. Flow
+$1.81B
Cap. Flow %
2.4%
Top 10 Hldgs %
12.06%
Holding
4,018
New
612
Increased
1,577
Reduced
1,314
Closed
496

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$798M
2
NFLX icon
Netflix
NFLX
+$608M
3
UNH icon
UnitedHealth
UNH
+$517M
4
AAPL icon
Apple
AAPL
+$461M
5
GEV icon
GE Vernova
GEV
+$296M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Healthcare 15.8%
3 Consumer Discretionary 12.38%
4 Financials 11.53%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHV icon
3526
Achieve Life Sciences
ACHV
$659M
-87,886
Closed -$235K
ACLX
3527
DELISTED
Arcellx
ACLX
-68,000
Closed -$4.46M
ADM icon
3528
Archer Daniels Midland
ADM
$38.2B
-265,900
Closed -$12.8M
AFRM icon
3529
Affirm
AFRM
$23.9B
-818,900
Closed -$37M
AGYS icon
3530
Agilysys
AGYS
$2.97B
-14,200
Closed -$1.03M
AIG icon
3531
American International
AIG
$41.7B
-92,700
Closed -$8.06M
AIR icon
3532
AAR Corp
AIR
$5.59B
-38,260
Closed -$2.14M
ALLK
3533
DELISTED
Allakos
ALLK
-869,311
Closed -$198K
AMAT icon
3534
Applied Materials
AMAT
$403B
-112,348
Closed -$16.3M
AMD icon
3535
Advanced Micro Devices
AMD
$776B
-3,195,790
Closed -$328M
AMZN icon
3536
Amazon
AMZN
$2.92T
-2,246
Closed -$427K
ANVS icon
3537
Annovis Bio
ANVS
$74.4M
-21,800
Closed -$32.7K
AON icon
3538
Aon
AON
$76.5B
-35,101
Closed -$14M
ARES icon
3539
Ares Management
ARES
$28.9B
-203,700
Closed -$29.9M
ARI
3540
Apollo Commercial Real Estate
ARI
$867M
-326,340
Closed -$3.12M
ARKF icon
3541
ARK Blockchain & Fintech Innovation ETF
ARKF
$722M
-16,400
Closed -$545K
ARKK icon
3542
ARK Innovation ETF
ARKK
$5.64B
-94,900
Closed -$4.52M
ARKW icon
3543
ARK Web x.0 ETF
ARKW
$1.63B
-6,300
Closed -$596K
ARQT icon
3544
Arcutis Biotherapeutics
ARQT
$3.36B
-21,799
Closed -$341K
ASML icon
3545
ASML
ASML
$626B
-485
Closed -$325K
AVNT icon
3546
Avient
AVNT
$3.33B
-21,358
Closed -$794K
JBIO
3547
Jade Biosciences
JBIO
$1.2B
-1,543
Closed -$136K
AVXL icon
3548
Anavex Life Sciences
AVXL
$255M
-14,000
Closed -$120K
AXDX
3549
DELISTED
Accelerate Diagnostics
AXDX
-64,200
Closed -$45K
AZTA icon
3550
Azenta
AZTA
$1.3B
-16,344
Closed -$566K

Similar funds

Renaissance Technologies's Q2 2025 Portfolio in Review

As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
  • Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
  • Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
  • Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
  • Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
  • Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.

Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.